GET DAILY SIGNALSWhy Is NVE Corporation (NVEC) Stock Down 29.72% Today?
Key Takeaways
- Shares plunged roughly 29.72% intraday to about $72.44, down from a prior close of $103.07.
- The primary catalyst was second-quarter fiscal 2027 results, which showed an 8% year-over-year revenue decline and softer profit.
- A 95% drop in defense product sales and a short-term inventory adjustment at a large medical-device customer drove the revenue shortfall.
- The selloff comes despite a 67% surge in distributor sales and management guidance for a recovery in the current quarter.
- Traders are watching whether medical-device and defense orders rebound as management expects in the fiscal third quarter.
Opening Summary
NVE Corporation (NVEC), the Eden Prairie, Minnesota-based developer of spintronic sensors and isolators used in industrial, medical, automotive, and defense applications, saw its stock tumble sharply in Thursday's session. Shares fell about 29.72%, changing hands near $72.44 versus a prior close of $103.07. The move lower followed the company's fiscal second-quarter earnings report, released after Wednesday's close, which revealed an 8% decline in total revenue and a year-over-year contraction in profit that outweighed pockets of strength in the commercial and distribution channels.
Earnings-Driven Move: Revenue and Profit Decline
The selloff was squarely an earnings-driven move. For the quarter ended September 30, 2026, total revenue decreased 8% year over year, driven by a 9% decline in product sales that was only partially offset by a 25% increase in contract research and development revenue. Net income slipped to $3.17 million, or $0.65 per diluted share, compared with $3.31 million, or $0.68 per share, in the prior-year quarter. While gross margin held near 78% and the net margin improved to 54% on a lower effective tax rate, the top-line deterioration and sequential slowdown sparked a sharp market reaction from investors who had bid the stock higher on the strength of a blowout June quarter.
Product Sales Headwinds: Defense and Medical-Device Volatility
The revenue decline was concentrated in two areas. Defense product sales fell 95% from a year earlier, which management attributed to the inherent variability of government procurement cycles rather than a loss of underlying demand. Separately, a large medical-device customer carried out a short-term inventory adjustment, pulling orders into the prior quarter and temporarily slowing the flow of direct product sales. Management characterized both disruptions as temporary, noting that revenue had already begun to reaccelerate toward the end of the September quarter, with September orders stronger than August.
Signs of Strength and Management's Outlook
Beneath the headline miss, there were notable bright spots. Distributor sales surged 67% year over year, reflecting strengthening industrial conditions and demand for new and legacy commercial products. Over the first six months of fiscal 2027, total revenue reached $16.9 million, up 36% from the prior-year period, and net income rose to $9.57 million, or $1.97 per diluted share. Management also highlighted growing traction in robotics, factory automation, and power conversion, supported by the launch of new wafer-level chip-scale sensors and a family of gear sensors. The company guided for medical-device and defense sales to recover in the current quarter and for second-half fiscal 2027 revenue to be consistent with the first half.
Market Context and Trading Activity
The decline was accompanied by significantly elevated volume, with turnover well above the stock's typical daily average, reflecting heavy repositioning as investors digested the results. The move diverged from broader market and semiconductor-sector trends, underscoring that the selloff was company-specific rather than a symptom of macro or sector-wide weakness. Technically, the sharp gap lower pushed shares decisively through prior support levels and well below recent moving averages, adding to the bearish intraday momentum as momentum-oriented traders and stop-loss selling compounded the initial earnings reaction. The stock's relatively small float and thin trading depth can amplify such moves in either direction.
What Comes Next for NVEC
Investors will now focus on whether the expected recovery materializes. Key watch items include the trajectory of medical-device and defense orders in the fiscal third quarter, the durability of distributor-led commercial growth, and any further updates on the company's emerging robotics and automation design wins. The company's ability to sustain its $1.00 quarterly dividend — which currently exceeds trailing earnings — and its strong cash position of about $44.4 million in cash and marketable securities will also remain in focus. Risks include continued order lumpiness, customer concentration, and the absence of specific forward revenue guidance, which leaves the stock sensitive to near-term order-flow surprises.
Trending AI Robots
Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in its curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and traded symbols, giving traders a way to screen for systematic approaches that are performing well right now. Explore the Trending AI Robots page to see which strategies are currently leading the market.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
NVEC in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 14, 2026
NVEC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 28 of 33 cases where NVEC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where NVEC advanced for three days, in 225 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The Aroon Indicator entered an Uptrend today. In 179 of 227 cases where NVEC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
Bearish Trend Analysis
The 10-day RSI Indicator for NVEC moved out of overbought territory on October 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 25 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 74%.
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NVEC as a result. In 55 of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 58%.
The Moving Average Convergence Divergence Histogram (MACD) for NVEC turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 28 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 55%.
NVEC moved below its 50-day moving average on October 14, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for NVEC crossed bearishly below the 50-day moving average on October 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 58%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVEC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 31 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.
The Tickeron SMR rating for this company is 34 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. NVEC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.340) is normal, around the industry mean (6.538). P/E Ratio (27.707) is within average values for comparable stocks, (23.955). NVEC's Projected Growth (PEG Ratio) (71.130) is very high in comparison to the industry average of (3.761). NVEC has a moderately high Dividend Yield (0.039) as compared to the industry average of (0.011). P/S Ratio (15.106) is also within normal values, averaging (45.794).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of devices using spintronics
Industry Semiconductors
Advertisement